azacitidine
SpainDrugs containing this active substance
-
It is used in adults who are not candidates for a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).
Form: powder for injectable suspension
Active substance Dosage azacitidine Igual a 100 mg mg Manufacturer: Accord Healthcare S.L.U.
-
It is used in adults who are unable to receive a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). These disorders affect the bone marrow and the production of blood cells.
Form: powder for injectable suspension
Active substance Dosage azacitidine 100 mg Manufacturer: Betapharm Arzneimittel Gmbh
-
It is used in adults who are unable to receive a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). These diseases affect the bone marrow and the production of blood cells.
Form: powder for injectable suspension
Active substance Dosage azacitidine 100 mg Manufacturer: Eugia Pharma (Malta) Limited
-
It is used in adults who cannot receive a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). These diseases affect the bone marrow and the production of blood cells.
Form: powder for injectable suspension
Active substance Dosage azacitidine 25 mg/ml Manufacturer: Hikma Farmaceutica (Portugal) S.A.
-
It is used in adults who are unable to receive a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). These diseases affect the bone marrow and the production of blood cells.
Form: powder for injectable suspension
Active substance Dosage azacitidine 100 mg Manufacturer: Mylan Ireland Limited
-
It is used in adults who are unable to receive a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).
Form: powder for injectable suspension
Active substance Dosage azacitidine 100 mg Manufacturer: Sandoz Farmaceutica S.A.
-
It is used in adults who are not candidates for a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).
Form: powder for injectable suspension
Active substance Dosage azacitidine 100 mg Manufacturer: Seacross Pharma (Europe) Limited
-
It is used in adults who are not candidates for a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).
Form: powder for injectable suspension
Active substance Dosage azacitidine 100 mg Manufacturer: Zentiva K.S.
-
It is used in adults who are not candidates for a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). These diseases affect the bone marrow and the production of blood cells.
Form: powder for injectable suspension
Active substance Dosage azacitidine 100 mg Manufacturer: Zentiva K.S.
-
It is used to treat adults with acute myeloid leukemia (AML), a type of cancer that affects the bone marrow, in order to keep the disease under control.
Form: tablets, film-coated
Active substance Dosage azacitidine 200 mg Manufacturer: Bristol-Myers Squibb Pharma Eeig
-
It is used to treat adults with acute myeloid leukemia (AML), a type of cancer that affects the bone marrow, in order to keep the disease under control.
Form: tablets, film-coated
Active substance Dosage azacitidine 300 mg Manufacturer: Bristol-Myers Squibb Pharma Eeig
-
It is used in adults who cannot receive a stem cell transplant to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML). These diseases affect the bone marrow and blood cell production.
Form: powder for injectable suspension
Active substance Dosage azacitidine 25 mg Manufacturer: Bristol-Myers Squibb Pharma Eeig